nodes	percent_of_prediction	percent_of_DWPC	metapath
Etomidate—SLC2A1—endothelium—colon cancer	0.108	0.174	CbGeAlD
Etomidate—SLC2A1—blood vessel—colon cancer	0.1	0.16	CbGeAlD
Etomidate—SLC2A1—embryo—colon cancer	0.0597	0.0956	CbGeAlD
Etomidate—SLC2A1—epithelium—colon cancer	0.0487	0.078	CbGeAlD
Etomidate—SLC2A1—renal system—colon cancer	0.0452	0.0723	CbGeAlD
Etomidate—CYP11B2—renal system—colon cancer	0.0387	0.0619	CbGeAlD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—ODC1—colon cancer	0.0378	0.101	CbGpPWpGaD
Etomidate—SLC2A1—lymphoid tissue—colon cancer	0.0375	0.0601	CbGeAlD
Etomidate—SLC2A1—digestive system—colon cancer	0.037	0.0593	CbGeAlD
Etomidate—SLC2A1—bone marrow—colon cancer	0.0341	0.0547	CbGeAlD
Etomidate—SLC2A1—vagina—colon cancer	0.0327	0.0524	CbGeAlD
Etomidate—SLC2A1—liver—colon cancer	0.0276	0.0442	CbGeAlD
Etomidate—CYP11B2—Metapathway biotransformation—CHST4—colon cancer	0.0228	0.0607	CbGpPWpGaD
Etomidate—SLC2A1—lymph node—colon cancer	0.0212	0.0339	CbGeAlD
Etomidate—CYP11B1—Metapathway biotransformation—CHST4—colon cancer	0.0196	0.0523	CbGpPWpGaD
Etomidate—SLC2A1—HIF-1-alpha transcription factor network—HNF4A—colon cancer	0.0185	0.0492	CbGpPWpGaD
Etomidate—CYP11B2—lymph node—colon cancer	0.0181	0.029	CbGeAlD
Etomidate—SLC2A1—Carbohydrate metabolism—CHST5—colon cancer	0.0146	0.0389	CbGpPWpGaD
Etomidate—SLC2A1—HIF-1-alpha transcription factor network—ABCB1—colon cancer	0.0115	0.0307	CbGpPWpGaD
Etomidate—CYP19A1—Metapathway biotransformation—CHST4—colon cancer	0.0111	0.0296	CbGpPWpGaD
Etomidate—CYP11B2—Metapathway biotransformation—CHST5—colon cancer	0.0105	0.0279	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—RAD54L—colon cancer	0.00949	0.0253	CbGpPWpGaD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—BAX—colon cancer	0.00945	0.0252	CbGpPWpGaD
Etomidate—CYP11B1—Metapathway biotransformation—CHST5—colon cancer	0.00902	0.024	CbGpPWpGaD
Etomidate—SLC2A1—HIF-2-alpha transcription factor network—EP300—colon cancer	0.00893	0.0238	CbGpPWpGaD
Etomidate—CYP19A1—liver—colon cancer	0.00873	0.014	CbGeAlD
Etomidate—SLC2A1—HIF-2-alpha transcription factor network—VEGFA—colon cancer	0.00846	0.0225	CbGpPWpGaD
Etomidate—CYP19A1—Ovarian Infertility Genes—MLH1—colon cancer	0.00792	0.0211	CbGpPWpGaD
Etomidate—CYP11B2—ACE Inhibitor Pathway—TGFB1—colon cancer	0.00707	0.0188	CbGpPWpGaD
Etomidate—CYP19A1—lymph node—colon cancer	0.00669	0.0107	CbGeAlD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—ODC1—colon cancer	0.00575	0.0153	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CA7—colon cancer	0.00573	0.0152	CbGpPWpGaD
Etomidate—SLC2A1—HIF-1-alpha transcription factor network—EP300—colon cancer	0.00525	0.014	CbGpPWpGaD
Etomidate—CYP19A1—Metapathway biotransformation—CHST5—colon cancer	0.00511	0.0136	CbGpPWpGaD
Etomidate—SLC2A1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—colon cancer	0.00506	0.0135	CbGpPWpGaD
Etomidate—SLC2A1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	0.00497	0.0132	CbGpPWpGaD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—EP300—colon cancer	0.00455	0.0121	CbGpPWpGaD
Etomidate—SLC2A1—Disease—LGR5—colon cancer	0.00414	0.011	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CHST5—colon cancer	0.00414	0.011	CbGpPWpGaD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—MYC—colon cancer	0.00396	0.0106	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CHST5—colon cancer	0.00347	0.00924	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—ODC1—colon cancer	0.00347	0.00924	CbGpPWpGaD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—TP53—colon cancer	0.00325	0.00867	CbGpPWpGaD
Etomidate—SLC2A1—HIF-1-alpha transcription factor network—AKT1—colon cancer	0.00317	0.00845	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—MSH6—colon cancer	0.00313	0.00834	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CA7—colon cancer	0.003	0.00798	CbGpPWpGaD
Etomidate—SLC2A1—Disease—AXIN2—colon cancer	0.00298	0.00793	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—BRAF—colon cancer	0.0027	0.00719	CbGpPWpGaD
Etomidate—CYP19A1—FSH signaling pathway—SRC—colon cancer	0.00267	0.0071	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CA7—colon cancer	0.00258	0.00687	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—MSH2—colon cancer	0.00254	0.00676	CbGpPWpGaD
Etomidate—SLC2A1—NRF2 pathway—TGFB1—colon cancer	0.00242	0.00644	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—CASP3—colon cancer	0.00203	0.00539	CbGpPWpGaD
Etomidate—SLC2A1—Transmembrane transport of small molecules—ABCB1—colon cancer	0.00196	0.00521	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—CTNNB1—colon cancer	0.00195	0.0052	CbGpPWpGaD
Etomidate—SLC2A1—Insulin Signaling—PIK3CA—colon cancer	0.00191	0.00509	CbGpPWpGaD
Etomidate—ADRA2B—Platelet Aggregation (Plug Formation)—SRC—colon cancer	0.00187	0.00498	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ODC1—colon cancer	0.00181	0.00483	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CHST5—colon cancer	0.00181	0.00483	CbGpPWpGaD
Etomidate—SLC2A1—Insulin Signaling—HRAS—colon cancer	0.00177	0.00471	CbGpPWpGaD
Etomidate—CYP19A1—FSH signaling pathway—AKT1—colon cancer	0.00166	0.00441	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—TGFB1—colon cancer	0.00158	0.0042	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CHST5—colon cancer	0.00156	0.00416	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ODC1—colon cancer	0.00156	0.00416	CbGpPWpGaD
Etomidate—SLC2A1—Insulin Signaling—AKT1—colon cancer	0.00156	0.00416	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CA7—colon cancer	0.00146	0.00389	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—BAX—colon cancer	0.00144	0.00383	CbGpPWpGaD
Etomidate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—colon cancer	0.00129	0.00344	CbGpPWpGaD
Etomidate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—colon cancer	0.00118	0.00315	CbGpPWpGaD
Etomidate—ADRA2B—Platelet Aggregation (Plug Formation)—AKT1—colon cancer	0.00116	0.0031	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—AKT1—colon cancer	0.0011	0.00292	CbGpPWpGaD
Etomidate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—colon cancer	0.00103	0.00275	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—BRAF—colon cancer	0.00103	0.00274	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—CDH1—colon cancer	0.00101	0.00268	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—BRAF—colon cancer	0.000971	0.00259	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—ABCB1—colon cancer	0.000917	0.00244	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—TYMS—colon cancer	0.000901	0.0024	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—BRAF—colon cancer	0.000889	0.00237	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CHST5—colon cancer	0.000886	0.00236	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ODC1—colon cancer	0.000886	0.00236	CbGpPWpGaD
Etomidate—SLC2A1—Disease—FGFR3—colon cancer	0.00086	0.00229	CbGpPWpGaD
Etomidate—SLC2A1—Disease—APC—colon cancer	0.000789	0.0021	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—BRAF—colon cancer	0.000777	0.00207	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—colon cancer	0.000772	0.00206	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—colon cancer	0.000752	0.002	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.000749	0.00199	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—BRAF—colon cancer	0.000744	0.00198	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	0.000744	0.00198	CbGpPWpGaD
Etomidate—SLC2A1—Disease—BRAF—colon cancer	0.000742	0.00198	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—DLC1—colon cancer	0.000712	0.00189	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—CASP3—colon cancer	0.00071	0.00189	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—EP300—colon cancer	0.000692	0.00184	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—CTNNB1—colon cancer	0.000685	0.00182	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—BRAF—colon cancer	0.000681	0.00181	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—LGR5—colon cancer	0.000669	0.00178	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—colon cancer	0.000655	0.00174	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.000646	0.00172	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PPARG—colon cancer	0.000638	0.0017	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—EP300—colon cancer	0.000636	0.00169	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—VEGFA—colon cancer	0.000603	0.00161	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—MYC—colon cancer	0.000603	0.00161	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PTGS2—colon cancer	0.000599	0.0016	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—BRAF—colon cancer	0.000595	0.00158	CbGpPWpGaD
Etomidate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—colon cancer	0.000594	0.00158	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000591	0.00157	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—colon cancer	0.00059	0.00157	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.000589	0.00157	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—colon cancer	0.000557	0.00148	CbGpPWpGaD
Etomidate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—colon cancer	0.000543	0.00145	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—ABCB1—colon cancer	0.00054	0.00144	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CTNNB1—colon cancer	0.000536	0.00143	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CDKN1A—colon cancer	0.000524	0.00139	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.000508	0.00135	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PTGS2—colon cancer	0.000502	0.00134	CbGpPWpGaD
Etomidate—SLC2A1—Disease—EP300—colon cancer	0.000498	0.00133	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—TP53—colon cancer	0.000495	0.00132	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—EP300—colon cancer	0.00049	0.00131	CbGpPWpGaD
Etomidate—SLC2A1—Disease—SRC—colon cancer	0.000485	0.00129	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AXIN2—colon cancer	0.000481	0.00128	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ABCB1—colon cancer	0.00048	0.00128	CbGpPWpGaD
Etomidate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—colon cancer	0.000475	0.00126	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000472	0.00126	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—TYMS—colon cancer	0.000471	0.00125	CbGpPWpGaD
Etomidate—SLC2A1—Disease—NRAS—colon cancer	0.000466	0.00124	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—SRC—colon cancer	0.000448	0.00119	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—HRAS—colon cancer	0.000447	0.00119	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—colon cancer	0.000436	0.00116	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MYC—colon cancer	0.000434	0.00116	CbGpPWpGaD
Etomidate—SLC2A1—Disease—TGFB1—colon cancer	0.000433	0.00115	CbGpPWpGaD
Etomidate—SLC2A1—Disease—EGFR—colon cancer	0.000425	0.00113	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	0.000422	0.00112	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—colon cancer	0.000418	0.00111	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—EP300—colon cancer	0.000417	0.00111	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ABCB1—colon cancer	0.000413	0.0011	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—HRAS—colon cancer	0.000409	0.00109	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—TYMS—colon cancer	0.000406	0.00108	CbGpPWpGaD
Etomidate—SLC2A1—Disease—KRAS—colon cancer	0.000401	0.00107	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—colon cancer	0.0004	0.00107	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PIK3CA—colon cancer	0.000369	0.000982	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.000366	0.000974	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	0.000363	0.000965	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—HRAS—colon cancer	0.000357	0.000951	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—HRAS—colon cancer	0.000342	0.000911	CbGpPWpGaD
Etomidate—SLC2A1—Disease—HRAS—colon cancer	0.000341	0.000908	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	0.000341	0.000907	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PPARG—colon cancer	0.000334	0.000888	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—HRAS—colon cancer	0.000313	0.000833	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	0.000312	0.000832	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PIK3CA—colon cancer	0.000309	0.000822	CbGpPWpGaD
Etomidate—SLC2A1—Disease—AKT1—colon cancer	0.000301	0.000802	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.000288	0.000766	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PPARG—colon cancer	0.000288	0.000766	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—AKT1—colon cancer	0.000278	0.000741	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—HRAS—colon cancer	0.000274	0.000728	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PTGS2—colon cancer	0.000262	0.000699	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—AKT1—colon cancer	0.000252	0.000672	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	0.000239	0.000637	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—EP300—colon cancer	0.000237	0.000632	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ABCB1—colon cancer	0.000234	0.000624	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—SRC—colon cancer	0.000231	0.000615	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—TYMS—colon cancer	0.00023	0.000612	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PTGS2—colon cancer	0.000226	0.000602	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—VEGFA—colon cancer	0.000225	0.000599	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—NRAS—colon cancer	0.000222	0.000591	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—EP300—colon cancer	0.000218	0.000581	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TGFB1—colon cancer	0.000206	0.000549	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—KRAS—colon cancer	0.000191	0.000509	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—EP300—colon cancer	0.000188	0.000501	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	0.000177	0.000471	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PIK3CA—colon cancer	0.000176	0.000468	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TP53—colon cancer	0.00017	0.000452	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PPARG—colon cancer	0.000163	0.000434	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—HRAS—colon cancer	0.000162	0.000433	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PIK3CA—colon cancer	0.000161	0.00043	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—AKT1—colon cancer	0.000143	0.000382	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PIK3CA—colon cancer	0.000139	0.000371	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FGFR3—colon cancer	0.000139	0.00037	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—AKT1—colon cancer	0.000132	0.000351	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PTGS2—colon cancer	0.000128	0.000341	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APC—colon cancer	0.000127	0.000339	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—NRAS—colon cancer	0.000127	0.000339	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—BRAF—colon cancer	0.00012	0.000319	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—EGFR—colon cancer	0.000116	0.000309	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—AKT1—colon cancer	0.000114	0.000303	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PIK3CA—colon cancer	0.000111	0.000295	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—KRAS—colon cancer	0.00011	0.000292	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—EP300—colon cancer	0.000107	0.000284	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PIK3CA—colon cancer	0.000101	0.000268	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HRAS—colon cancer	9.32e-05	0.000248	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—AKT1—colon cancer	9.07e-05	0.000241	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CASP3—colon cancer	8.98e-05	0.000239	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCND1—colon cancer	8.74e-05	0.000233	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CTNNB1—colon cancer	8.66e-05	0.000231	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CDKN1A—colon cancer	8.46e-05	0.000225	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—AKT1—colon cancer	8.23e-05	0.000219	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EP300—colon cancer	8.05e-05	0.000214	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PIK3CA—colon cancer	7.89e-05	0.00021	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SRC—colon cancer	7.83e-05	0.000208	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—VEGFA—colon cancer	7.62e-05	0.000203	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NRAS—colon cancer	7.53e-05	0.0002	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MYC—colon cancer	7.01e-05	0.000187	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TGFB1—colon cancer	7e-05	0.000186	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EGFR—colon cancer	6.86e-05	0.000183	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—KRAS—colon cancer	6.48e-05	0.000173	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—AKT1—colon cancer	6.44e-05	0.000172	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PIK3CA—colon cancer	5.95e-05	0.000159	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TP53—colon cancer	5.76e-05	0.000153	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HRAS—colon cancer	5.51e-05	0.000147	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AKT1—colon cancer	4.86e-05	0.000129	CbGpPWpGaD
